MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 364 filers reported holding MEDIVATION INC in Q1 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $5,042,000 | +40.6% | 83,610 | +7.2% | 0.39% | +150.0% |
Q1 2016 | $3,586,000 | -7.3% | 78,000 | -2.5% | 0.16% | -41.4% |
Q4 2015 | $3,867,000 | +44.4% | 80,000 | +27.0% | 0.27% | +125.4% |
Q3 2015 | $2,678,000 | +95.5% | 63,000 | +425.0% | 0.12% | +118.5% |
Q2 2015 | $1,370,000 | -49.5% | 12,000 | -42.9% | 0.05% | -55.0% |
Q1 2015 | $2,711,000 | +48.1% | 21,000 | -26.1% | 0.12% | +224.3% |
Q1 2014 | $1,830,000 | -66.1% | 28,430 | -68.4% | 0.04% | -36.2% |
Q3 2013 | $5,394,000 | +143.6% | 90,000 | +100.0% | 0.06% | -10.8% |
Q2 2013 | $2,214,000 | – | 45,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |